Science and technology in Argentina heart transplant field. They have also contributed to bioscience in efforts like the Human Genome Project, where Argentine scientists have successfully mapped the genome of a living being, a world first. Argentina has its own satellite programme, nuclear power station designs (4th generation) and public nuclear energy company INVAP, which provides several countries with nuclear reactors. Other projects are focusing on IS, nanotechnology, biotechnology, helicopters, farming machinery and military defensive systems. Established in 1991, the CONAE has since launched 8 indigenous built satellites successfully, AMSAT, MuSat, SAC-B, SAC-A, SAC-C, SAC-D/Aquarius, ARSAT I and ARSAT-2. In June 2009, secured an agreement
Artificial cell cells have been proposed as a non-viral vector by which genetically modified non-autologous cells are encapsulated and implanted to deliver recombinant proteins "in vivo". This type of immuno-isolation has been proven efficient in mice through delivery of artificial cells containing mouse growth hormone which rescued a growth-retardation in mutant mice. A few strategies have advanced to human clinical trials for the treatment of pancreatic cancer, lateral sclerosis and pain control. The first clinical use of artificial cells was in hemoperfusion by the encapsulation of activated charcoal. Activated charcoal has the capability of adsorbing many large molecules and has for a